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QVH (one’s dose distribution being compared to the other’s 
dose prescription). 
Results 
Image analysis 
At each time point, FDG vs FAZA voxel-by-voxel comparison 
showed high correlation (rs = 0.78 IQR [0.69-0.83]). Similarly, 
uptake distributions were spatially stable between imaging 
sessions for both tracers (FDG: rs = 0.90 [0.85-0.94]; FAZA: rs 
= 0.89 [0.75-0.91]).  
FDG and FAZA median SUV increased linearly from r1 to r5.  
All results were significant (p < 0.01). 
Adaptive planning 
Conformity of FDG and FAZA DPBN plans was achieved (QF = 
1.33 ± 0.19 %). 
At each time point, cross QVH between FDG/FAZA DPBN 
prescriptions and geometric plans showed satisfactory QF 
(FDG: 2.99 ± 0.15 %; FAZA: 3.03 ± 0.21 %) meaning plans 
could be swapped. 
Cross QVH between pre-treatment plans and per-treatment 
prescriptions had acceptable QF as well (FDG: 2.05 ± 0.82 %; 
FAZA: 2.39 ± 0.92 %). 
Conclusions: FDG and FAZA did not clearly show different 
uptake patterns, nor significant temporal changes during RT. 
Notably, the linear increase of SUV towards the center of the 
GTV probably reflects the lack of tracer specificity and the 
typical blur of PET images. As a result, dose distributions 
were highly similar between DPBN and geometric plans. 
Therefore, a CT-based geometric dose escalation might be a 
simpler, as effective, alternative. 
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Purpose/Objective: 10 year follow up after hypo-
fractionated radiation therapy in breast cancer has been 
reported as safe and effective. Maximum lung distance (LD) 
at mid slice (MS), all slices (AS) and maximum heart distance 
(HD) MS or AS has traditionally been used to reduce 
pneumonitis or ischaemic cardiac effects post radiation. 
Improvements in planning with forward planned IMRT (FIMRT) 
often use shielding of heart and lung using mini segments to 
reduce irradiated heart/lungs. This study reports the dose 
volume (DV) correlates for whole breast and chest wall 
planning and analyses if traditional 2d distances (LD MS/AS or 
HD MS/AS) are relevant surrogates for use in the current era. 
Materials and Methods: Plans for 496 consecutive patients' 
who underwent FIMRT to the whole breast or chest wall (and 
/or supraclavicular fossa) to a dose of 4005 cGy in 15 
fractions were analysed. All plans were accepted with target 
coverage between 95-107%. LD MS/AS, HD MS/AS were 
recorded. Mean heart dose(MHD), V2.5, V5 and V30 of heart 
(left sided cancers), mean lung dose (MLD), V5/V10/V20 of 
ipsilateral lung were analyzed from DV histograms (DVH). The 
DVH data was compared for correlation with 2d LD and HD, 
pearsons correlation(r ) calculated and significance analysed. 
Other DVH comparisons, left vs right, whole-breast (WBRT) vs 
chest wall irradiation (CWRT) were compared using the 
Independent samples T test. 
Results: 290 and 206 patients underwent WBRT and CWRT, 
frequency of left vs right were 49.%8, 50.2% respectively. The 
mean of the LD-MS was 2.1 cm (range - 0.5 cm to 3.4 cm) and 
LD-AS was 2.3 cm (range - 0.80 to 3.7 cm).The MLD was 638.8 
cGy (range - 14.6 cGy to 1115.3 cGy). Mean of V5, V10, V20 
of ipsilateral lung were 21.7, 15.6 and 12.8 % respectively. 
Lung V5, V10, V20, MLD, were higher with right sided 
irradiation (p < 0.005). HD MS/AS were 0.6/1.9 cm 
respectively, MHD, V2.5, V5 and V30 in the left sided breast 
cancers were 396.0 cGy (range – 22.8 cGy to 858 cGy), 20.1, 
11.3 and 6.0 % respectively. When comparing WBRT and 
CWRT, the mean LD-MS, LD-AS, V10 and V20 were 
significantly less (p <0.005) with WBRT although there 
weren't any difference in heart DVH. LD-MS correlated 
strongly (P=<0.005) with V5,V10, V20, MLD (r=0.6, 0.7, 0.7, 
0.7) with Linear coefficient (R2)ratio between 0.4-0.5. A 
significant reduction (range 22-46.4%) in V5/10/20 was seen 
with a 5mm 2dLD reduction. HD-AS correlated significantly 
(p<0.005) with V2.5, V5, V30, MHD (r=0.9 for all AND R2 =0.8). 
A 2mm change above 1.7-2.1mm resulted significant DV heart 
changes. 
Conclusions: Significant correlation existed between 2d LD 
and HD with the lung, heart dosimetric parameters 
reiterating their use as surrogate markers to predict lung and 
heart toxicities, even in the era of FIMRT. Significant DVH 
changes can occur with 5mm 2dLD and 2dHD changes, 
highlighting the benefit of segment shielding of heart and 
lungs in breast radiotherapy. 
 
PO-0789 
Trends in DVH metrics of OAR’s and tumor in 3 consecutive 
TPS for 270 HNC patients: an automated institutional 
analysis 
J.J. Posma1, L.C. Persoon1, D.B. Eekers1, E.G. Troost1, 
M. Granzier1, G. Bosmans1, S.M. Nijsten1, F.J. Hoebers1 
1GROW School for Oncology and Developmental Biology  
Maastricht University Medical Centre, 
Department of Radiation Oncology (MAASTRO Clinic), 
Maastricht, The Netherlands 
 
Purpose/Objective: Over the past years, treatment for Head 
and Neck Cancer (HNC) has evolved from relatively simple 3D 
conformal therapy to IMRT with static beams and more 
recently to volumetric modulated arc therapy (VMAT) 
techniques using rotational beams. Previous planning studies 
have shown benefits from these modern treatment planning 
systems (TPS) and techniques, but mainly in small and 
selected patient series.  
The purpose of the current study was to quantify the effects 
on dose-volume histogram (DVH) parameters for various 
treatment techniques and 3 different treatment planning 
systems (TPS’s). This was done on a large scale population 
basis using the actual treatment plans delivered in routine 
daily practice. 
Materials and Methods: Between 2006 and 2013, a total of 
270 patients with primary HNC underwent radiation therapy 
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with curative intent (66-70 Gy). We compared three different 
TPS: XiO® (CMS/Elekta, 2006-2010, step-and-shoot IMRT), 
Monaco® (CMS/Elekta, 2011-2012, step-and-shoot IMRT), and 
Eclipse™ (Varian Medical Systems, 2012-2013, RapidArc). We 
analyzed delineation volumes and several DVH parameters, 
including maximum and mean dose (Dmax and Dmean, 
respectively) and the volumes receiving 45 and 54 Gy (V45Gy, 
and V54Gy) of several organs at risk (OARs): salivary glands, 
oral cavity, spinal cord and brainstem. All data were 
retrieved automatically from Maastro Clinic’s Data 
Warehouse that contains data from the TPS, R&V systems, 
treatment machines and electronic medical file. Based on the 
DICOM-RT data from the TPS, all relevant DVH data were 
recomputed using the same DVH engine for all different 
TPS’s. 
Results: The volumes of the OARs were relatively stable 
thoughout the study period with differences of 5-10%. The 
results of the analysis of DVH parameters are given in table 
1. 
 
 
The average Dmean of both parotid glands reduced 
significantly from XiO, to Monaco, and Eclipse. The 
percentage of parotid glands receiving a Dmean <26 Gy 
increased by approximately 30%: from 45% with XiO to 32% 
with Eclipse. Similarly, also for the Oral Cavity an improved 
sparing was achieved using Monaco and Eclipse. No 
statistically significant changes in dose to the submandibular 
glands were observed, due to the proximity of this OAR to 
the target-volume.  
Average Dmax and V45Gy to the spinal cord were both also 
significantly lowered, indicating facilitated sparing with the 
VMAT technique employed in Eclipse. The average Dmax to 
the Brainstem again showed similar reductions with VMAT. 
Conclusions: Using an automated analysis we have 
demonstrated improved sparing of several important OARs 
over time with the implementation of modern state-of-the-
art TPS and new treatment techniques in a large population-
based planning study. Analysis of target coverage is ongoing. 
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Purpose/Objective: New national guidelines (GL) for 
radiotherapy (RT) of head and neck cancer (HNC) were 
implemented at the beginning of 2013. One purpose of the 
new GL was to nationally standardise the expansion from GTV 
to high risk CTV (CTV1). This standardisation has resulted in 
change of volume of CTV1 for most institutions which 
previously used different margins. Change in CTV1 volume 
definition could influence the risk and time evolution of 
adverse effects e.g. mucositis. This study investigates change 
in acute response during RT in a centre where GTV to CTV1 
margin was increased from 0 to 5mm. 
Materials and Methods: All patients (n=592) receiving 
curative RT for HNC from Jan 2011 to Sep 2014 were 
included, 292 patients treated according to the old GL and 
300 according to the new GL. Tumour doses were 66-68 Gy in 
33-34 fx with 5 or 6/10 fx/w. All were treated with IMRT 
except for simple glottic tumours. Acute skin and mucosal 
reactions were scored weekly during RT, and 2 and 8 weeks 
after (0 none, 1 erythema, 2 dry desquamation/patchy 
mucositis, 3 wet desquamation/confluent mucositis, 4 
ulceration). Use of analgesics was recorded equivalently on a 
5-point scale. Clinical endpoints were dichotomized, grade 0-
1 vs 2+ or 0-2 vs 3+. 
Potential change in actuarial cumulative incidence (One 
minus the Kaplan Meier estimator) of mucositis was tested 
using the log-rank test. To stratify for the potential effect 
between non-accelerated (5 fx/w) and accelerated (6/10 
fx/w) treatments, a Cox regression analysis including the 
covariates: acceleration, old/new GL, and their interaction 
product was performed. Potential differences between 
patient demographics were tested using a chi-square test. 
Results: The new GL increased the risk of grade 2+ mucositis 
during RT (p = 0.02) as demonstrated by a ~20%-point 
increase at the end of RT for the non-accelerated group, but 
not in the accelerated group. In Cox regression, all covariates 
were significantly associated with grade 2+ and 3+ mucositis 
(acceleration, p<0.001; GL, p=0.02). The interaction term 
was negative indicating that the impact of GL on acute 
response was dependent on the fractionation schedule 
(Figure). For skin reactions and use of analgesics, there were 
no observed differences between the old and the new GLs. 
No differences in demographics (gender, age, site, stage) 
were observed between the groups 
